1. Home
  2. UNTY vs CELC Comparison

UNTY vs CELC Comparison

Compare UNTY & CELC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNTY
  • CELC
  • Stock Information
  • Founded
  • UNTY 1991
  • CELC 2011
  • Country
  • UNTY United States
  • CELC United States
  • Employees
  • UNTY N/A
  • CELC N/A
  • Industry
  • UNTY Major Banks
  • CELC Medical Specialities
  • Sector
  • UNTY Finance
  • CELC Health Care
  • Exchange
  • UNTY Nasdaq
  • CELC Nasdaq
  • Market Cap
  • UNTY 453.3M
  • CELC 489.7M
  • IPO Year
  • UNTY 1997
  • CELC 2017
  • Fundamental
  • Price
  • UNTY $47.15
  • CELC $10.93
  • Analyst Decision
  • UNTY Buy
  • CELC Strong Buy
  • Analyst Count
  • UNTY 2
  • CELC 6
  • Target Price
  • UNTY $54.50
  • CELC $29.17
  • AVG Volume (30 Days)
  • UNTY 48.1K
  • CELC 356.6K
  • Earning Date
  • UNTY 01-15-2025
  • CELC 11-14-2024
  • Dividend Yield
  • UNTY 1.10%
  • CELC N/A
  • EPS Growth
  • UNTY 5.73
  • CELC N/A
  • EPS
  • UNTY 4.06
  • CELC N/A
  • Revenue
  • UNTY $103,131,000.00
  • CELC N/A
  • Revenue This Year
  • UNTY N/A
  • CELC N/A
  • Revenue Next Year
  • UNTY $11.86
  • CELC N/A
  • P/E Ratio
  • UNTY $11.61
  • CELC N/A
  • Revenue Growth
  • UNTY 3.16
  • CELC N/A
  • 52 Week Low
  • UNTY $25.33
  • CELC $10.35
  • 52 Week High
  • UNTY $48.44
  • CELC $22.19
  • Technical
  • Relative Strength Index (RSI)
  • UNTY 63.28
  • CELC 35.65
  • Support Level
  • UNTY $38.93
  • CELC $10.35
  • Resistance Level
  • UNTY $41.93
  • CELC $13.80
  • Average True Range (ATR)
  • UNTY 1.53
  • CELC 0.83
  • MACD
  • UNTY 0.50
  • CELC -0.19
  • Stochastic Oscillator
  • UNTY 90.24
  • CELC 16.20

About UNTY Unity Bancorp Inc.

Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.

About CELC Celcuity Inc.

Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.

Share on Social Networks: